Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Orthofix International PLC Q1 2026 Earnings Call - Spine Distributor Shift Drives Momentum, Biologics Turnaround Underway
Orthofix International delivered a disciplined start to 2026, with Q1 net sales rising 3% year-over-year to $196.4 million, supported by a strategic pivot toward larger, more dedicated spine distribut...
- Q1 2026 net sales rose 3% year-over-year to $196.4 million on a pro forma constant currency basis, landing within the range implied by full-year guidance.
- U.S. spine fixation net sales grew 4%, with the top 30 distributor partners delivering 27% year-over-year growth as the company’s channel transition strategy matures.
- Management confirmed spine distributor transitions are largely complete, with a new leadership structure simplifying decision-making and bringing oversight closer to the field.
- +7 more takeaways
Sequans Communications Q1 2026 Earnings Call - Sequans Purges Debt, Holds 600 Bitcoin, and Bets on 5G IoT
Sequans Communications is shedding its crypto-driven debt burden to refocus on its core IoT semiconductor business. The company plans to fully redeem its $94.5 million convertible debt by June 1, 2026...
- Sequans will fully redeem $94.5 million in convertible debt by June 1, 2026, funded by selling Bitcoin collateral, leaving a near debt-free balance sheet.
- Post-debt redemption, Sequans will hold at least 600 unencumbered Bitcoin, which management plans to monetize opportunistically rather than reinvest.
- Q1 2026 revenue was $6.1 million, in line with expectations, driven by product sales despite variability in licensing and service revenue timing.
- +7 more takeaways
Ferguson Q1 2026 Earnings Call - Non-Residential Growth Offsets Weak Residential Amid Inflation and M&A Expansion
Ferguson delivered a solid Q1 2026 performance with sales of $7.5 billion, up 3.6% year-over-year, driven by strong non-residential growth (up 8%) that offset a challenging residential market (down 1%...
- Sales of $7.5 billion increased 3.6% year-over-year, with 2.8% organic growth and 0.8% from acquisitions.
- Operating profit grew 8.4%, expanding operating margins by 40 basis points to 8.7%, driving a 9.1% increase in diluted EPS to $2.28.
- Non-residential revenue surged 8%, significantly outperforming the market, driven by large capital projects and a 18% jump in commercial mechanical sales.
- +7 more takeaways
Fortrea Holdings Inc Q1 2026 Earnings Call - AI Integration and Biotech Momentum Drive Margin Expansion
Fortrea Holdings delivered a solid first quarter in 2026, marking a strong start with revenue of $636.5 million and adjusted EBITDA of $47 million. The company is on track to meet its full-year guidan...
- Q1 2026 revenue was $636.5 million, a 2.3% year-over-year decline, primarily driven by lower pass-through costs in clinical pharmacology and clinical development, though underlying full-service clinical revenue grew.
- Adjusted EBITDA reached $47 million, up from $30.3 million in the prior year period, supported by cost savings initiatives and improved project mix.
- Book-to-bill ratio was 1.15x for the quarter and 1.05x on a trailing twelve-month basis, reflecting the third consecutive quarter of book-to-bill ratios at or above 1.1x.
- +12 more takeaways
UFP Technologies Q1 2026 Earnings Call - New Program Ramps and Leadership Transition Drive Growth Amid Non-Medical Softness
UFP Technologies reported a 4.1% revenue increase in Q1 2026, driven by a 5.9% rise in medical sales that was partially offset by a 15% decline in non-medical revenue. The company is navigating a stra...
- Revenue grew 4.1% year-over-year, with medical sales rising 5.9% while non-medical sales fell 15% as the company exits lower-growth segments.
- EPS growth trailed revenue growth due to startup costs from four simultaneous program launches, labor inefficiencies at the AJR facility, and non-recurring legal expenses from a cyber attack and CEO transition.
- Four major programs are in the ramp phase, with three new customers already requesting doubled capacity, signaling strong early demand for UFP’s med-tech expansions.
- +7 more takeaways
Great Elm Capital Corp Q1 2026 Earnings Call - NAV Protection Takes Precedence Over Income Generation
Great Elm Capital Corp navigated a volatile first quarter of 2026 by pivoting sharply toward capital preservation. New CEO Jason Reese has elevated NAV protection above income generation, a shift unde...
- New CEO Jason Reese has explicitly reprioritized the company’s strategy, making NAV protection and growth the primary objective, with income generation as a secondary goal.
- The company waived all accrued and unpaid incentive fees through June 30, 2026, marking the third consecutive quarter of waivers and providing approximately $0.20 per share in direct benefit to shareholders.
- GECC called and repurchased all $57.5 million of GECCO notes due later this year, eliminating near-term refinancing risk and pushing the next funded debt maturity to 2029.
- +7 more takeaways
Cipher Digital Q1 2026 Earnings Call - Hyperscale Execution, $11.4B Contracted Revenue, and Strategic Pivot to HPC
Cipher Digital’s Q1 2026 marks a definitive pivot from Bitcoin mining to institutional-grade HPC data center development, anchored by a third lease with an investment-grade hyperscale tenant and $2.2B...
- Third Hyperscale Lease Signed: Cipher secured a 15-year lease with an investment-grade tenant for a 100 MW site, bringing total contracted revenue to $11.4B across three major campuses.
- $2.2B Financing Package: Completed a $2B high-yield bond offering for the Black Pearl project and closed a $200M corporate revolving credit facility, significantly de-risking construction execution.
- Barber Lake Construction Velocity: Topped out structural steel in just 127 days from first column, with 99% of equipment secured and 1.4M+ daily active workers on site, maintaining a zero lost-time incident record.
- +9 more takeaways
AudioCodes Q1 2026 Earnings Call - Voice AI and Recurring Revenue Momentum Accelerate
AudioCodes delivered a solid first quarter in 2026, with total revenues rising 2.9% year-over-year to $62.1 million. The company’s strategic pivot toward a voice AI-driven hybrid cloud model is gainin...
- Total Q1 2026 revenue reached $62.1 million, up 2.9% year-over-year, with services accounting for 54.7% of the mix.
- Live managed services and conversational AI combined to generate $80 million in annual recurring revenue, growing nearly 20% year-over-year.
- Conversational AI revenue grew over 50% year-over-year, representing roughly 8% of total revenue and signaling rapid enterprise adoption.
- +9 more takeaways
Neuronetics Q1 2026 Earnings Call - New CEO Pivots Strategy Amid Cash Constraints and Strategic Review Pressure
Neuronetics reported Q1 2026 revenue of $34.5 million, an 8% year-over-year increase, driven by a 15% rise in U.S. clinic revenue. The new CEO, Dan Reuvers, emphasized a shift toward flexible commerci...
- Total revenue increased 8% year-over-year to $34.5 million, primarily driven by a 15% surge in U.S. clinic revenue.
- U.S. NeuroStar system revenue grew 13% to $3.2 million, with 34 systems shipped, up 10% year-over-year.
- U.S. treatment session revenue declined 5% to $9.1 million, offsetting a 3.5% increase in treatment utilization due to lower customer inventory levels.
- +9 more takeaways
SelectQuote Q3 Fiscal 2026 Earnings Call - Surge in Cash Flow Visibility Amid Valuation Disconnect
SelectQuote delivered a robust third fiscal quarter, posting $431 million in revenue and $45 million in adjusted EBITDA, driven by resilient performance in its Medicare Advantage and healthcare servic...
- SelectQuote reported $431 million in revenue for Q3 fiscal 2026, a 6% year-over-year increase, demonstrating resilience across its core segments.
- Adjusted EBITDA reached $45 million, representing an 18% year-over-year growth, though this was partially boosted by a non-recurring favorable adjustment.
- The senior business generated $183 million in revenue, up 8% year-over-year, driven by a 4% increase in approved Medicare Advantage policies and strong agent productivity.
- +7 more takeaways